Related Experiment Videos
Characterization of 3LL-tumor variants generated by in vitro macrophage-mediated selection
Abstract:
Following sequential interactions between activated syngeneic M phi s and 3LL tumor cells, stable M phi-resistant 3LL variants were isolated. Unlike the unselected 3LL cells, these M phi-selected variants were relatively resistant to the cytostatic and cytolytic activity of activated effector M phi s. Such M phi-resistant 3LL variants evade the M phi tumoricidal activity by at least two mechanisms. Firstly, they manifest a reduced susceptibility towards M phi-related cytotoxins such as TNF. Secondly, they actively suppress the cytotoxic potential of M phi s through secretion of M phi-inhibitory factors. The resistance of the 3LL variants to M phi effector cells in vitro was reflected in vivo by a higher tumorigenic and metastatic potential. No strict correlation was found between the NK sensitivity of M phi-resistant and M phi-sensitive 3LL cells and their metastatic ability. Hence, activated tumoricidal M phi s may play a central role in either the elimination or selection of neoplastic cells.
Insights
Tumor cells can develop resistance to macrophage (M phi) attack through reduced susceptibility to toxins and by secreting inhibitory factors. This macrophage resistance enhances tumor growth and metastasis, highlighting M phi s
Area of Science:
- Immunology
- Cancer Biology
- Tumor Microenvironment
Background:
- Activated macrophages (M phi s) are crucial in anti-tumor immunity, mediating cytostatic and cytolytic effects against neoplastic cells.
- Tumor cells can evolve resistance mechanisms to evade immune surveillance and destruction by effector cells like macrophages.
- Understanding tumor cell-macrophage interactions is vital for developing effective cancer immunotherapies.
Purpose of the Study:
- To investigate the mechanisms by which 3LL tumor cells acquire resistance to activated syngeneic macrophages (M phi s).
- To determine the impact of M phi resistance on the tumorigenic and metastatic potential of 3LL variants.
- To elucidate the role of activated tumoricidal M phi s in the selection or elimination of neoplastic cells.
Main Methods:
- Isolation of M phi-resistant 3LL variants following sequential interactions with activated M phi s.
- Assessment of M phi-induced cytostatic and cytolytic activity against M phi-sensitive and M phi-resistant 3LL cells in vitro.
- Analysis of M phi-related cytotoxin (e.g., TNF) susceptibility and secretion of M phi-inhibitory factors.
- Evaluation of tumorigenic and metastatic potential of M phi-resistant 3LL variants in vivo.
- Correlation analysis between Natural Killer (NK) cell sensitivity and metastatic ability.
Main Results:
- Stable M phi-resistant 3LL variants were successfully isolated, exhibiting reduced susceptibility to M phi cytostatic and cytolytic activity.
- M phi-resistant 3LL variants employed at least two evasion mechanisms: reduced susceptibility to M phi cytotoxins (like TNF) and active suppression of M phi cytotoxic potential via secreted factors.
- In vivo studies demonstrated a higher tumorigenic and metastatic potential for M phi-resistant 3LL variants compared to unselected 3LL cells.
- No strict correlation was observed between NK cell sensitivity and the metastatic ability of M phi-resistant versus M phi-sensitive 3LL cells.
Conclusions:
- Activated tumoricidal macrophages (M phi s) play a significant role in either eliminating or selecting for neoplastic cells based on their resistance profiles.
- Tumor cell resistance to macrophage-mediated cytotoxicity, achieved through specific molecular mechanisms, directly contributes to increased tumor aggressiveness and metastatic spread.
- The findings underscore the dynamic interplay between tumor cells and the immune microenvironment, suggesting that immune pressure can drive tumor evolution towards more aggressive phenotypes.